Safety and Tolerability of ZE74-0282 in Healthy Volunteers
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This first-in-human, randomized, double-blind, placebo-controlled Phase 1 study evaluates the safety, tolerability, and pharmacokinetics of single, split, and multiple oral doses of ZE74-0282 under fasted or fed conditions in healthy adult volunteers.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-55 lat
- •Stan zdrowia bez poważnych schorzeń
- •Masa ciała pomiędzy 50-100 kg (wskaźnik BMI 18-32)
- •Normalne ciśnienie krwi (90-160/50-95 mmHg)
- •Normalna czynność serca bez nieprawidłowości
- •Zdolność do wyrażenia świadomej zgody na uczestnictwo w badaniu
- •Kobiety: niedawno przebadane na ciążę - wynik negatywny
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 55 Years
- Last updated (source)
- July 28, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Scientia Clinical Research Ltd.
Randwick, Australia
Trial contact
Ekaterina Dokukina
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/29/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.